BDBM72325 3-[(2-chlorophenyl)sulfamoyl]-N-[(5-methyl-2-furanyl)methylideneamino]benzamide::3-[(2-chlorophenyl)sulfamoyl]-N-[(5-methyl-2-furyl)methyleneamino]benzamide::3-[(2-chlorophenyl)sulfamoyl]-N-[(5-methylfuran-2-yl)methylideneamino]benzamide::MLS000393884::SMR000247306::cid_2094276

SMILES O=C1c2cc(F)c(Cl)cc2N2CN1c1ccc(=O)[nH]c1CCNCc1cc(F)ccc12

InChI Key InChIKey=SFMGCASPQWRGSS-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72325   

TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 72325BDBM72325(3-Chloro-2,8-difluoro-10,11,12,13-tetrahydro-19H-5...)
Affinity DataIC50: 10nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2026
Entry Details
US Patent